author-photo

Daniel Poon

Chiron Corporation

1

Papers

24

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

CHIR-265 is a potent selective inhibitor of c-Raf/B-Raf/mutB-Raf that effectively inhibits proliferation and survival of cancer cell lines with Ras/Raf pathway mutations

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (24)